Hypha Labs, Inc. reported a significant financial downturn in its latest 10-K filing for the fiscal year ending September 30, 2025. The company, which transitioned from a cannabis testing laboratory to a developer of a home appliance for mushroom cultivation, recorded no revenue for the year, a stark contrast to the $1.6 million generated in the previous fiscal year from its discontinued operations. The net loss for the year was $3.1 million, compared to a loss of $785,429 in the prior year, reflecting a substantial increase in operating expenses, which rose to $3 million from $1.8 million.
The company's operational shift was marked by the sale of its subsidiary, Digipath Labs, on February 20, 2024, which effectively ended its previous business model. Following this sale, Hypha Labs established Hypha Products, Inc. to focus on the development of the Hypha Micropearl accelerator, a device designed to produce nutritionally beneficial mushrooms at home. The company plans to continue product design and testing over the next year, with a goal to launch commercially by late 2026, although it cautions that there are no guarantees regarding this timeline.
In terms of operational metrics, Hypha Labs reported a current asset total of $320,531 as of September 30, 2025, down from $410,190 the previous year. Current liabilities surged to $2.5 million, leading to a working capital deficit of $2.2 million. The company had a total of 147.1 million shares of common stock outstanding, with a market price of $0.038 as of January 13, 2026. The employee headcount stood at five, with no union representation.
The filing also highlighted the company's ongoing challenges, including a lack of sufficient cash reserves to sustain operations and the need for additional financing to support its business strategy. The company has expressed substantial doubt about its ability to continue as a going concern, emphasizing the risks associated with its new business model and the competitive landscape of the functional mushroom market, which is projected to grow significantly in the coming years. Hypha Labs is actively seeking to raise capital to fund its operations and product development, but it acknowledges the uncertainty surrounding its ability to secure necessary financing.
About Hypha Labs, Inc.
Hypha Labs, Inc. develops innovative bioreactor technology for home-based production of functional mushrooms, enabling consumers to grow nutritionally beneficial Micropearls. The company focuses on research, development, and commercialization of its devices and cartridges, targeting the health and wellness market. Its core value lies in providing lab-quality mushroom ingredients conveniently for food and beverage use, disrupting traditional cultivation methods and expanding access to medicinal fungi.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.